Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_assertion description "[In addition, ladostigil significantly upregulated mRNA levels of several antioxidant enzymes (catalase, NAD(P)H quinone oxidoreductase 1 and peroxiredoxin 1) in both H(2)O(2)-treated SH-SY5Y cells, as well as in the high-density human SK-N-SH neuroblastoma cultured apoptotic models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_assertion evidence source_evidence_literature NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_assertion SIO_000772 18751929 NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_assertion wasDerivedFrom befree-2016 NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_assertion wasGeneratedBy ECO_0000203 NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.
- befree-2016 importedOn "2016-02-19" NP690001.RAQivRLAaPgeiMz_NUCxBRBbO_l6bGEFw5EbQwjX6racw130_provenance.